INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE);ENS - ECOLE NORMALE SUPERIEURE DE LYON;UNIVERSITE CLAUDE BERNARD - LYON 1;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS);HOSPICE
发明人:
Antoine SICARD,Olivier THAUNAT
申请号：
US16776642
公开号：
US20200261597A1
申请日:
2020.01.30
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention relates to biofunctionalized nanoparticles and uses thereof in adoptive cell therapy. In particular, the present invention relates to a nanoparticle comprising an amount of at least one antigen and an amount of at least one antibody having specificity for a B cell receptor wherein the antigen and antibody are attached to the surface of the nanoparticle.
